These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3076984)

  • 1. IgA-specific Fc receptor and immunoglobulin factor.
    Yodoi J
    Tokai J Exp Clin Med; 1988 Dec; 13(4-5):171-4. PubMed ID: 3076984
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
    Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
    J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc epsilon receptors on T and B lymphocytes.
    Huff TF; Yodoi J; Uede T; Ishizaka K
    J Immunol; 1984 Jan; 132(1):406-12. PubMed ID: 6197453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Fc receptors for IgA on murine T cell hybridoma by human monoclonal IgA and by high molecular weight IgA in IgA nephropathy.
    Chevailler A; Monteiro RC; Daëron M; Lesavre P
    Clin Exp Immunol; 1987 Jan; 67(1):114-23. PubMed ID: 3497739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody (G6) inhibiting IgA binding to fixed Fc alpha R(+) T2D4 cells. Monoclonal antibody recognizing IgA-binding sites on fixed T2D4 cells.
    Tokumoto H; Shimada T; Doi T; Takeuchi E; Kawabe T; Yoshida H; Yodoi J
    Monogr Allergy; 1988; 24():208-14. PubMed ID: 3258954
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble FcR block suppressor T cell activity at low concentration in vitro allowing isotype-specific antibody production.
    Simpson SD; Snider DP; Zettel LA; Kiyono H; Unkeless JC; Ernst PB
    Cell Immunol; 1996 Jan; 167(1):122-8. PubMed ID: 8548835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characteristics of IgA and IgM Fc binding to the Fcalpha/muR.
    Cho Y; Usui K; Honda S; Tahara-Hanaoka S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2006 Jun; 345(1):474-8. PubMed ID: 16681999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues.
    Sakamoto N; Shibuya K; Shimizu Y; Yotsumoto K; Miyabayashi T; Sakano S; Tsuji T; Nakayama E; Nakauchi H; Shibuya A
    Eur J Immunol; 2001 May; 31(5):1310-6. PubMed ID: 11465087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA; van Egmond M
    Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA receptors in health and disease.
    Wines BD; Hogarth PM
    Tissue Antigens; 2006 Aug; 68(2):103-14. PubMed ID: 16866880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
    van Egmond M; van Garderen E; van Spriel AB; Damen CA; van Amersfoort ES; van Zandbergen G; van Hattum J; Kuiper J; van de Winkel JG
    Nat Med; 2000 Jun; 6(6):680-5. PubMed ID: 10835685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against the Fc fragment of IgA alpha-chain: preparation and clinical application.
    Yan PH; Ahmad S; He Q
    Biochem Mol Biol Int; 1994 Oct; 34(3):587-94. PubMed ID: 7833836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function of immunoglobulin A in immunity.
    Woof JM; Kerr MA
    J Pathol; 2006 Jan; 208(2):270-82. PubMed ID: 16362985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc receptors as regulatory molecules.
    Ann Inst Pasteur Immunol (1985); 1985; 136C(3):383-437. PubMed ID: 3876072
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies.
    van Seventer GA; Kuijpers KC; van Lier RA; de Groot ER; Aarden LA; Melief CJ
    J Immunol; 1987 Oct; 139(8):2545-50. PubMed ID: 3498763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB; Ballister ER; Bjorkman PJ
    Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isotypic circuit: immunoglobulins, Fc receptors and immunoglobulin binding factors.
    Fridman WH; Teillaud JL; Amigorena S; Daëron M; Blank U; Néauport-Sautès C
    Int Rev Immunol; 1987 Jan; 2(2):221-40. PubMed ID: 3333781
    [No Abstract]   [Full Text] [Related]  

  • 18. Opsonic, cytotoxic, precipitating, blocking of bacterial adherence, and other activities of monoclonal IgE antibody compared with IgA and IgM.
    Tlaskalová-Hogenová H; Simecková J; Vĕtvicka V; Fornůsek L; TalaFantová M; Mancal P
    Immunology; 1984 Nov; 53(3):427-33. PubMed ID: 6436172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
    Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
    J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte surface membrane immunoglobulin in myeloma. III. IgA plasmacytomas induce large numbers of circulating, adult-thymectomy-sensitive, theta +, Lyt-1-2+ lymphocytes with IgA-Fc receptors.
    Hoover RG; Dieckgraefe BK; Lake J; Kemp JD; Lynch RG
    J Immunol; 1982 Dec; 129(6):2329-31. PubMed ID: 6982915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.